Hardgrave J E, Heller R A, Herrera M G, Scallen T J
Proc Natl Acad Sci U S A. 1979 Aug;76(8):3834-8. doi: 10.1073/pnas.76.8.3834.
The immunotitration of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase [mevalonate:NADP+ oxidoreductase [CoA-acylating), EC 1.1.1.34], the major regulatory enzyme in cholesterol biosynthesis, by HMG-CoA reductase antiserum is described. This technique provides the advantage that one can rapidly measure relative changes in both enzyme concentration and enzyme activity in different physiological states by using enzyme samples all the way from crude liver microsomes to purified enzyme. Regarding the diurnal rhythm of HMG-CoA reductase, the major difference noted between animals killed near the middle of the dark period (D 4.5) compared to animals killed near the middle of the light period (L 4.5) was in the concentrations of HMG-CoA reductase present, rather than in the activity of the enzyme, with substantially more enzyme found near mid-dark. Cholestyramine treatment resulted in both an increased concentration of HMG-CoA reductase and a catalytically more active enzyme. On the other hand, cholesterol feeding resulted in both a decreased concentration of HMG-CoA reductase and a catalytically less active enzyme.
本文描述了用3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶抗血清对胆固醇生物合成中的主要调节酶HMG-CoA还原酶[甲羟戊酸:NADP +氧化还原酶(辅酶A酰化),EC 1.1.1.34]进行免疫滴定的方法。该技术的优点在于,从粗制肝微粒体到纯化酶的各种酶样品,都能快速测量不同生理状态下酶浓度和酶活性的相对变化。关于HMG-CoA还原酶的昼夜节律,在黑暗期中间附近(D 4.5)处死的动物与光照期中间附近(L 4.5)处死的动物相比,主要差异在于HMG-CoA还原酶的浓度,而非酶活性,在接近黑暗中期时发现的酶量更多。消胆胺处理导致HMG-CoA还原酶浓度增加,且酶的催化活性更高。另一方面,喂食胆固醇导致HMG-CoA还原酶浓度降低,且酶的催化活性更低。